Saturday, November 17, 2012

Chair: Jang-Yang Chang (張俊彥)

09:00 – 09:10

Opening Remarks

Wen-Ta Chiu
(
邱文達)
Lu-Hai Wang
(
王陸海)

Keynote Lecture

Chair: Ding-Shinn Chen (陳定信)

09:25 – 10:10

Overview and Perspective of Viral Oncogenesis
(No recording without authorization)

Kuan-Teh Jeang

HBV Session

Chairs: Jacqueline Whang-Peng (彭汪嘉康), Miin-Fu Chen (陳敏夫)

10:30 – 11:15

HBV Genotype and Hepatocellular Carcinoma

Joseph J. Y. Sung

11:15 – 11:40

Molecular and Genomic Biomarkers for the Prediction of Long-term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

Chien-Jen Chen
(陳建仁)

11:40 – 12:05

Viral Oncoproteins-driven Signaling Pathway and HBV Tumorigenesis: Implication for Chemoprevention in High Risk HBV Carriers

Ih-Jen Su
(蘇益仁)

12:05 – 12:30

Impact of Virologic Factors on Recurrence-free Survival in HBV-related Hepatocellular Carcinoma after Surgical Resection – Post-hoc Analysis from a Prospective Study with Long-term Follow-up
(No recording without authorization)

Li-Tzong Chen
(陳立宗)


HCV Session

Chairs: Ming-Chiao Lai (賴明詔), Masao Omata

13:30 – 14:15

Treatment of HCV: New Era with Direct Acting Antiviral Drugs

Wolf Peter Hofmann

14:15 – 14:40

Sex Hormones in Hepatitis Virus-related Liver Carcinogenesis

Pei-Jer Chen
(陳培哲)

14:40 – 15:05

Treatment of Chronic Hepatitis C in Taiwan

Wan-Long Chuang
(莊萬龍)

15:05 – 15:30

HBV and HCV Dual Infection: Clinical and Therapeutic Issues

Jia-Horng Kao
(高嘉宏)

HPV Session

Chairs: Chi-An Chen (陳祈安), Fu-Shing Liu (劉復興)

15:50 – 16:15

Human Papillomavirus and Human Evolution and Migration: Partnership of Millions Years

Tang-Yuan Chu
(朱堂元)

16:15 – 17:00

Low-cost Molecular Marker for Cervical Cancer Screening -- A Population-based Clinical Evaluation

You-Lin Qiao

17:00 – 17:25

HPV and Cervical Cancer in Taiwan
(No recording without authorization)

Angel Chao
(趙安琪)

17:25 – 17:50

HPV and Lung Cancer

Huei Lee
(
李輝)


Sunday, November 18, 2012

EBV Session

Chairs: Hwei-Fang Tien (田蕙芬)

9:00 – 9:25

Matrix Metalloproteinase 9 is a Convergent Effector for EBV-induced Cell Invasion
(No recording without authorization)

Yao Chang
(張堯)

9:25 – 9:50

Front-line Concurrent Chemoradiotherapy (CCRT) Followed Consolidation Chemotherapy in Localized Nasal NK/T-cell Lymphoma – TCOG T1405 Trial

Hui-Jen Tsai
(
蔡慧珍)

Chairs: Jen-Yang Chen (陳振陽), Jin-Ching Lin (林進清)

9:50 – 10:15

Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation versus Chemoradiation Alone for Patients with Stage IVA & IVB NPC -- Results of TCOG T1303 Study
(No recording without authorization)

Ruey-Long Hong
(
洪瑞隆)

10:15 – 10:45

Latest Advance in Salvage Surgery for Nasopharyngeal Carcinoma

Jimmy Yu-Wai Chan

10:45 – 11:15

Expression of Epstein-Barr Virus Encoded microRNA BART7 Enhances Radiation Sensitivity of Undifferentiated Nasopharyngeal Carcinoma

Stanley Thian-Sze Wong

11:15 – 11:25

Award Ceremony & Closing Remarks

Jang-Yang Chang
(
張俊彥)